The partnership between Trans Ova and TLG has been in development since the beginning of the year, with a focus on seamlessly integrating Trans Ova’s protocols into the TLG Camperdown facility. This process included extensive hands-on training for several TLG team members in the United States, ensuring that the services provided in Australia would meet the rigorous quality standards of the global leader. With all quality control checks now passed, the new laboratory is commercially creating IVF embryos for clients.

The collaboration is already gaining praise from key industry players. Genetics Australia’s chief executive officer, Anthony Shelly, has expressed his support for the partnership, highlighting the shared values between the two companies. He believes that gaining access to Trans Ova’s world-class technology will be highly beneficial for their clients, providing them with one of the best IVF solutions available globally.

Trans Ova Genetics is renowned internationally for its expertise in animal husbandry and reproductive science. The company operates through a comprehensive network that includes regional centres, satellite locations, and on-farm services, demonstrating its commitment to accessible, high-quality care. This integrated approach allows for efficient and widespread delivery of their advanced reproductive technologies to a diverse range of producers.